CLINICAL_TRIALS
trial_result
· 2015-01-14
Clinical Trial Update: ARTDIVA Study : First in Man Safety Evaluation of the ART18Z Bioresorbable Stent [NA]
Summary
The ARTDIVA Study reports the completion of the first-in-man safety evaluation of the ART18Z bioresorbable stent for coronary artery disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Arterial Remodeling Technologies | Conditions: Coronary Artery Disease | NA | Status: COMPLETED